TLATX
Price
$11.35
Change
+$0.09 (+0.80%)
Updated
Jan 17 closing price
Net Assets
167.33M
VFIAX
Price
$553.67
Change
+$5.49 (+1.00%)
Updated
Jan 17 closing price
Net Assets
1.35T
Ad is loading...

TLATX vs VFIAX

Header iconTLATX vs VFIAX Comparison
Open Charts TLATX vs VFIAXBanner chart's image
Transamerica Large Core ESG I3
Price$11.35
Change+$0.09 (+0.80%)
VolumeN/A
Net Assets167.33M
Vanguard 500 Index Admiral
Price$553.67
Change+$5.49 (+1.00%)
VolumeN/A
Net Assets1.35T
TLATX vs VFIAX Comparison Chart
Loading...
View a ticker or compare two or three
VS
TLATX vs. VFIAX commentary
Jan 19, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is TLATX is a Hold and VFIAX is a Hold.

Ad is loading...
FUNDAMENTALS
Fundamentals
VFIAX has more cash in the bank: 1.35T vs. TLATX (167M). VFIAX pays higher dividends than TLATX: VFIAX (1.32) vs TLATX (0.86). TLATX was incepted earlier than VFIAX: TLATX (8 years) vs VFIAX (24 years). TLATX is a more actively managed with annual turnover of: 98.00 vs. VFIAX (2.00). TLATX has a lower initial minimum investment than VFIAX: TLATX (0) vs VFIAX (3000). VFIAX annual gain was more profitable for investors over the last year : 25.54 vs. TLATX (1.99). VFIAX return over 5 years is better than : 80.23 vs. TLATX (7.56).
TLATXVFIAXTLATX / VFIAX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence8 years24 years-
Gain YTD2.4372.010121%
Front LoadN/AN/A-
Min. Initial Investment03000-
Min. Initial Investment IRAN/AN/A-
Net Assets167M1.35T0%
Annual Yield % from dividends0.861.3265%
Returns for 1 year1.9925.548%
Returns for 3 years-2.0731.13-7%
Returns for 5 years7.5680.239%
Returns for 10 yearsN/A196.98-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
LX6.790.45
+7.10%
LexinFintech Holdings Ltd
GATX154.690.58
+0.38%
GATX Corp
ALC84.370.23
+0.27%
Alcon
ANTX1.27N/A
N/A
AN2 Therapeutics
NMM42.48-1.07
-2.46%
Navios Maritime Partners LP